Baxter International Inc. BAX NYSE

Baxter International Inc. (BAX) reported total assets of $20.06B and total liabilities of $13.95B for fiscal year 2025, resulting in total equity of $6.1B.

The company held $1.97B in cash and short-term investments. Total debt stood at $10B, with net debt of $8.04B. The Debt-to-Equity (D/E) ratio was 1.64 (leveraged).

Current ratio is 2.31, indicating strong short-term liquidity. Interest coverage is -1.1x (weak).

Criteria supported by this page:

• HEALTH (33/100, Fail) — the balance sheet shows elevated risk in debt or liquidity metrics
• MOAT (49/100) — Total assets $20.06B and equity $6.1B support the company's competitive scale
• VALUE (78/100) — Debt-to-Equity 1.64 contributes to the overall valuation risk assessment

Overall SharesGrow Score: 43/100 with 2/7 criteria passed.

BDX

Becton, Dickinson and Company

$155.73

+0.19%

ALC

Alcon Inc.

$79.94

+0.25%

RMD

ResMed Inc.

$230.69

+0.19%

WST

West Pharmaceutical Services, Inc.

$267.93

+3.07%

HOLX

Hologic, Inc.

$76.01

+0.00%

COO

The Cooper Companies, Inc.

$71.61

-0.13%

MDGL

Madrigal Pharmaceuticals, Inc.

$524.99

-0.13%

DVA

DaVita Inc.

$149.45

-1.39%